Skip to main content

Venous Thromboembolism clinical trials at UCLA

2 in progress, 0 open to eligible people

Showing trials for
  • Pulmonary Embolism Prevention After Hip and Knee Replacement

    Sorry, in progress, not accepting new patients

    PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

    Los Angeles 5368361, California 5332921 and other locations

  • LMWH Vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

    Sorry, accepting new patients by invitation only

    Aspirin and low molecular weight heparin (LMWH) are both commonly employed pharmacologic methods of venous thromboembolism (VTE) prophylaxis after orthopaedic surgery. Data comparing these two methods of VTE prophylaxis in patients undergoing pelvic/lower extremity orthopaedic surgery for malignancy are lacking, however, as compared to the data and guidelines present for VTE chemoprophylaxis after joint arthroplasty and hip fracture surgery. In this clinical trial, our specific aim is to compare the post operative incidence of VTE between patients receiving aspirin and LMWH after pelvic/lower extremity orthopaedic oncology procedures.

    Los Angeles 5368361, California 5332921 and other locations

Last updated: